FDA announces review of asthma drug Xolair
Thursday, July 16, 2009 - 15:07
in Health & Medicine
WASHINGTON, July 16 (UPI) -- The U.S. Food and Drug Administration says it is conducting a safety review of Xolair, a drug used to treat moderate-to-severe persistent asthma.